DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,252 | +3.0% | 218,670 | -0.4% | 3.73% | +8.0% |
| Q2 2023 | $52,671 | -4.8% | 219,462 | -0.0% | 3.45% | -9.3% |
| Q1 2023 | $55,313 | -7.3% | 219,463 | -2.4% | 3.81% | -13.2% |
| Q4 2022 | $59,687 | -99.9% | 224,876 | -1.9% | 4.38% | -4.7% |
| Q3 2022 | $59,201,000 | +1.9% | 229,205 | +0.1% | 4.60% | +5.6% |
| Q2 2022 | $58,073,000 | -14.0% | 229,067 | -0.5% | 4.36% | +5.5% |
| Q1 2022 | $67,547,000 | -11.2% | 230,278 | -0.4% | 4.13% | -4.3% |
| Q4 2021 | $76,062,000 | +7.3% | 231,183 | -0.7% | 4.32% | -0.5% |
| Q3 2021 | $70,859,000 | +12.7% | 232,754 | -0.7% | 4.34% | +12.6% |
| Q2 2021 | $62,897,000 | +18.0% | 234,374 | -1.0% | 3.85% | +8.5% |
| Q1 2021 | $53,294,000 | +1.0% | 236,776 | -0.4% | 3.55% | -1.5% |
| Q4 2020 | $52,785,000 | +2.5% | 237,618 | -0.7% | 3.61% | -9.2% |
| Q3 2020 | $51,518,000 | +20.9% | 239,253 | -0.7% | 3.97% | +6.6% |
| Q2 2020 | $42,602,000 | +27.7% | 240,918 | -0.1% | 3.73% | -1.9% |
| Q1 2020 | $33,371,000 | -7.7% | 241,102 | +2.3% | 3.80% | +9.0% |
| Q4 2019 | $36,162,000 | +5.6% | 235,614 | -0.7% | 3.48% | -4.7% |
| Q3 2019 | $34,260,000 | +1.6% | 237,205 | +0.5% | 3.66% | +1.1% |
| Q2 2019 | $33,732,000 | +5.1% | 236,017 | -2.9% | 3.62% | +1.9% |
| Q1 2019 | $32,101,000 | +31.6% | 243,152 | +2.8% | 3.55% | +9.7% |
| Q4 2018 | $24,402,000 | -0.3% | 236,633 | +5.1% | 3.24% | +12.6% |
| Q3 2018 | $24,467,000 | +11.9% | 225,168 | +1.6% | 2.87% | +3.0% |
| Q2 2018 | $21,864,000 | +0.6% | 221,568 | -0.2% | 2.79% | +1.5% |
| Q1 2018 | $21,742,000 | +16.9% | 222,064 | +10.8% | 2.75% | +12.8% |
| Q4 2017 | $18,602,000 | +12.2% | 200,409 | +3.7% | 2.44% | +12.8% |
| Q3 2017 | $16,581,000 | +10.0% | 193,293 | +8.2% | 2.16% | +7.1% |
| Q2 2017 | $15,074,000 | +3.6% | 178,618 | +5.0% | 2.02% | +1.0% |
| Q1 2017 | $14,548,000 | +10.6% | 170,087 | +0.7% | 2.00% | +7.0% |
| Q4 2016 | $13,153,000 | +4.1% | 168,969 | +4.8% | 1.87% | +1.5% |
| Q3 2016 | $12,641,000 | -18.1% | 161,262 | +5.5% | 1.84% | -17.8% |
| Q2 2016 | $15,440,000 | +26.6% | 152,868 | +18.9% | 2.24% | +24.2% |
| Q1 2016 | $12,196,000 | +48.3% | 128,565 | +45.2% | 1.80% | +33.9% |
| Q4 2015 | $8,225,000 | +132.3% | 88,553 | +113.1% | 1.35% | +118.5% |
| Q3 2015 | $3,540,000 | +423.7% | 41,548 | +426.4% | 0.62% | +460.9% |
| Q2 2015 | $676,000 | -2.9% | 7,893 | -3.7% | 0.11% | -8.3% |
| Q1 2015 | $696,000 | -5.8% | 8,193 | -5.0% | 0.12% | -7.7% |
| Q4 2014 | $739,000 | +12.8% | 8,623 | 0.0% | 0.13% | +4.0% |
| Q3 2014 | $655,000 | -4.7% | 8,623 | -1.1% | 0.12% | -19.9% |
| Q2 2014 | $687,000 | +5.2% | 8,723 | +0.1% | 0.16% | +0.6% |
| Q1 2014 | $653,000 | -3.7% | 8,713 | -0.9% | 0.16% | -7.7% |
| Q4 2013 | $678,000 | +16.7% | 8,788 | +4.8% | 0.17% | +4.3% |
| Q3 2013 | $581,000 | +9.4% | 8,388 | 0.0% | 0.16% | +2.5% |
| Q2 2013 | $531,000 | – | 8,388 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |